The Global Peptic Ulcer Drugs Market is gaining momentum as gastrointestinal disease management becomes more important across aging populations and emerging healthcare systems. From USD 5.71 billion in 2025, the market is forecast to reach USD 9.74 billion by 2035, registering a 5.48% CAGR. Rising H. pylori prevalence, expanding insurance coverage, and increasing demand for effective acid-suppression treatments are supporting growth.

Traditional PPIs continue to form the foundation of the market because of their established clinical use and broad generic availability. At the same time, PCAB therapies are creating a new area of competition because of their rapid acid suppression and expanding indications. The growing PCAB pipeline is encouraging pharmaceutical companies to invest in alternative mechanisms and combination treatment approaches.

Gastric ulcers currently represent the largest disease segment, accounting for 43.0% of revenue in 2024. Duodenal and esophageal ulcers also contribute to demand, while stress-related mucosal damage is developing rapidly. Increasing awareness of H. pylori diagnosis and treatment is helping maintain demand for therapies that combine acid suppression with appropriate eradication regimens.

North America led the market with a 32.3% share in 2024, supported by high healthcare expenditure and widespread PPI use. Europe held 27.1%, while Asia-Pacific is projected to expand at the fastest regional CAGR of 5.58%. Government-supported H. pylori screening and improving access to gastrointestinal care are creating additional opportunities across Asia-Pacific markets.

The market's future is likely to be influenced by precision treatment, digital pharmacy, and improved medication adherence. Microbiome profiling could eventually help identify appropriate eradication strategies, while digital refill services and telehealth may make long-term therapy easier to manage. These innovations, combined with expanding PCAB pipelines, could reshape the competitive landscape of peptic ulcer treatment.

Access detailed findings to navigate market complexities:

Dermatology Lasers Market Trends

Anti-Fungal Drugs Market Growth

Graft Versus Host Disease Treatment Market Demand

Hunter Syndrome Treatment Market Volume

Cryptococcosis Market Forecast